Diabetes duration has minimal impact on SGLT2 inhibitor efficacy, as per new analysis

Retrieved on: 2024-08-31 18:46:41

Tags for this article:

SGLT2 inhibitors

Glucosides

Anti-diabetic drugs

Solute carrier family

Aging-associated diseases

Empagliflozin

Dapagliflozin

Canagliflozin

Sodium-glucose transport proteins

Sodium/glucose cotransporter 2

Diabetes

Eli Lilly and Company

dapagliflozin propanediol

Click the tags to see associated articles and topics

Diabetes duration has minimal impact on SGLT2 inhibitor efficacy, as per new analysis. View article details on hiswai:

Excerpt

... Innovation Rankings · Magazine · Newsletters. GlobalData. About us · Advertise ... Health Foundation Cardiovascular Research Centre, presented data ...

Article found on: www.pharmaceutical-technology.com

View Original Article